Tyrosine Kinase Inhibitors as Initial Therapy for Patients With Chronic Myeloid Leukemia in Accelerated Phase-Reference-Cited by-同舟云学术

Tyrosine Kinase Inhibitors as Initial Therapy for Patients With Chronic Myeloid Leukemia in Accelerated Phase

Published:2014-04 Issue:2 Volume:14 Page:155-162.e1
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Ohanian Maro,Kantarjian Hagop M.,Quintas-Cardama Alfonso,Jabbour Elias,Abruzzo Lynne,Verstovsek Srdan,Borthakur Gautam,Ravandi Farhad,Garcia-Manero Guillermo,Champlin Richard,Pierce Sherry,Alattar Mona Lisa,Trinh Long Xuan,Luthra Raja,Ferrajoli Alessandra,Kadia Tapan,O'Brien Susan,Cortes Jorge E.

Funder

M.D. Anderson Cancer Center

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference30 articles.

1. Survival benefit with imatinib mesylate therapy in patients with accelerated-phase chronic myelogenous leukemia–comparison with historic experience;Kantarjian;Cancer,2005

2. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome;Druker;N Engl J Med,2001

3. Natural history and staging of chronic myelogenous leukemia;Cortes;Hematol Oncol Clin North Am,2004

4. Characteristics of accelerated disease in chronic myelogenous leukemia;Kantarjian;Cancer,1988

5. Advanced-phase chronic myeloid leukemia;Cortes;Semin Hematol,2003

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Contemporary Role of Hematopoietic Stem Cell Transplantation in the Management of Chronic Myeloid Leukemia: Is It the Same in All Settings?;Cancers;2024-02-12

2. Stem cell allografting for chronic Myeloid leukemia in the tyrosine kinase era – forgotten but not gone;Leukemia & Lymphoma;2024-02-09

3. An Update on the Management of Advanced Phase Chronic Myeloid Leukemia;Current Hematologic Malignancy Reports;2023-08-31

4. First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia;Leukemia Research;2023-07

5. Classification of accelerated phase chronic myeloid leukemia in the era of the BCR::ABL1 tyrosine kinase inhibitors: A work in progress;American Journal of Hematology;2023-06-26